NEWS
LifeArc licenses lead stage molecules to Daiichi Sankyo

The deal to license an ion channel drug discovery programme marks the successful outcome of a collaboration between LifeArc, Oxford University’s NDCN and Daiichi Sankyo.

We have been a part of an exciting collaboration with Daiichi Sankyo and @NDCNOxford that advanced research into an… https://t.co/Dzxg9camKG
  • All
  • News Releases
  • Articles & blogs
  • Announcements
  • Events
    • News Releases
    16 April 2019
    LifeArc licenses lead stage molecules to Daiichi Sankyo
    News Releases
    27 March 2019
    Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance
    News Releases
    18 January 2019
    EB 2020 London – Save the date
    News Releases
    17 December 2018
    LifeArc launches Technology Transfer Fellowships
    News Releases
    12 December 2018
    LifeArc study points towards expanded utility for antibody-drug candidates
    News Releases
    4 December 2018
    GOSH Charity and LifeArc launch £1M grant scheme
    News Releases
    27 November 2018
    LifeArc and C4X Discovery join forces to develop small molecule drug candidates
    News Releases
    25 October 2018
    LifeArc® and Asthma UK® announce collaboration
    News Releases
    3 October 2018
    LifeArc joins the #RareYouthProject